SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Predictors of Response to Pharmacotherapy in Social Anxiety Disorder
0 references·14 citing·35 second hop
Predictors of Response to Pharmacotherapy in Social Anxiety Disorder (2002)Predictors of Response to Pharmacotherapy…Pharmacotherapy for social anxiety disorder (SAnD) (2017)Pharmacotherapy for social an…Influence of baseline severity on antidepressant efficacy for anxiety disorders: Meta-analysis and meta-regression (2016)Influence of baseline severit…Don't ask, don't tell: a systematic review of the extent to which participant characteristics are reported in social anxiety treatment studies (2016)Don't ask, don't tell: a syst…Social Anxiety Disorder (2015)Social Anxiety DisorderGeneralized social anxiety disorder: A still‐neglected anxiety disorder 3 decades since Liebowitz's review (2015)Generalized social anxiety di…A review on predictors of treatment outcome in social anxiety disorder (2012)A review on predictors of tre…Pharmacotherapy of social anxiety disorder (2011)Pharmacotherapy of social anx…Pharmacotherapy for social anxiety disorder: a systematic review (2008)Pharmacotherapy for social an…Optimizing Treatment in Social Phobia: A Review of Treatment Resistance (2004)Optimizing Treatment in Socia…Escitalopram in the treatment of social anxiety disorder: Analysis of efficacy for different clinical subgroups and symptom dimensions (2004)Escitalopram in the treatment…Social anxiety disorder (2003)Social anxiety disorderCitalopram treatment of social anxiety disorder with comorbid major depression (2003)Citalopram treatment of socia…Psychopharmacology of anxiety disorders (2002)Psychopharmacology of anxiety…Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder (2002)Moclobemide is effective and …Phenelzine vs Atenolol in Social Phobia (1992)Agoraphobia, Simple Phobia, and Social Phobia in the National Comorbidity Survey (1996)Psychometric properties of the Social Phobia Inventory (SPIN) (2000)Psychometric properties of the Liebowitz Social Anxiety Scale in a large cross-cultural Spanish and Portuguese speaking sample (2018)A RATING SCALE FOR DEPRESSION (1960)Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States (1994)Structured Clinical Interview for DSM-IV Axis I Disorders (1997)Predictors of persistence of social anxiety disorder: A national study (2011)Measuring inconsistency in meta-analyses (2003)Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication (2005)A Randomized Controlled Trial of Atomoxetine in Generalized Social Anxiety Disorder (2009)Therapeutic strategies for social anxiety disorder: where are we now? (2019)Emotion regulation: Affective, cognitive, and social consequences (2002)Diagnostic and Statistical Manual of Mental Disorders (2013)A New Depression Scale Designed to be Sensitive to Change (1979)Cognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia (1998)Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial (2003)A meta-analysis of pharmacotherapy for social anxiety disorder: an examination of efficacy, moderators, and mediators (2017)The treatment of social anxiety disorder (2004)Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication (2005)Predicting cognitive behavioral therapy outcome in the outpatient sector based on clinical routine data: A machine learning approach (2019)Clinical, genetic, and sociodemographic predictors of symptom severity after internet-delivered cognitive behavioural therapy for depression and anxiety (2025)Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 (2013)An Inventory for Measuring Depression (1961)Bias in meta-analysis detected by a simple, graphical test (1997)An integrated model to assess and treat compulsive sexual behaviour disorder (2020)Pharmacological treatments for social anxiety disorder in adults: a systematic review and network meta-analysis (2020)Pharmacotherapy for Anxiety Disorders: From First-Line Options to Treatment Resistance (2021)Diagnostic and Statistical Manual of Mental Disorders (2013)The Effectiveness of Group Emotional Schema Therapy on Emotional Regulation and Social Anxiety Symptoms (2018)The role of the acceptance and commitment therapy in the treatment of social anxiety: An updated scoping review (2022)The Ethics of Mandatory Exoskeleton Use in Commercial and Industrial Settings (2023)Multicenter Collaborative Panic Disorder Severity Scale (1997)Pilot study of secondary prevention of posttraumatic stress disorder with propranolol (2002)Anxious to see you: Neuroendocrine mechanisms of social vigilance and anxiety during adolescence (2019)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2017Pharmacotherapy for social anxiety disorder (SAnD)84 cited
  • 2008Pharmacotherapy for social anxiety disorder: a systematic review66 cited
  • 2002Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder65 cited
  • 2002Psychopharmacology of anxiety disorders64 cited
  • 2012A review on predictors of treatment outcome in social anxiety disorder59 cited
  • 2003Citalopram treatment of social anxiety disorder with comorbid major depression56 cited
  • 2015Social Anxiety Disorder52 cited
  • 2016Influence of baseline severity on antidepressant efficacy for anxiety disorders: Meta-analysis and meta-regression50 cited
  • 2004Escitalopram in the treatment of social anxiety disorder: Analysis of efficacy for different clinical subgroups and symptom dimensions47 cited
  • 2003Social anxiety disorder46 cited
  • 2004Optimizing Treatment in Social Phobia: A Review of Treatment Resistance44 cited
  • 2011Pharmacotherapy of social anxiety disorder41 cited
  • 2015Generalized social anxiety disorder: A still‐neglected anxiety disorder 3 decades since Liebowitz's review40 cited
  • 2016Don't ask, don't tell: a systematic review of the extent to which participant characteristics are reported in social anxiety treatment studies

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

12 cited